Article
A promising field: regulating imbalance of EndMT in cardiovascular diseases.
Cell cycle (Georgetown, Tex.) - 1 Aug 2021
Zhou Kun, Tian Kai-Jiang, Yan Bin-Jie, Gui Dan-Dan, Luo Wen, Ren Zhong, Wei Dang-Heng, Liu Lu-Shan, Jiang Zhi-Sheng
Abstract excerpt
Endothelial-mesenchymal transition (EndMT) is widely involved in the occurrence and development of cardiovascular diseases. Although there is no direct evidence, it is very promising as an effective target for the treatment of these diseases. Endothelial cells need to respond to the complex cardiovascular environment through EndMT, but sustained stimuli will cause the imbalance of EndMT. Blocking the signal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
